What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Epilepsy
- Gene
His main research concerns Epilepsy, Pediatrics, Anesthesia, Randomized controlled trial and Carbamazepine.
His Epilepsy study improves the overall literature in Psychiatry.
The study incorporates disciplines such as Clinical trial, Surgery, Neuropsychology, Electroencephalography and Lamotrigine in addition to Pediatrics.
His Anesthesia study combines topics in areas such as Drug withdrawal, Placebo, Internal medicine and Zonisamide.
His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Anticonvulsant, Epilepsy surgery, Meta-analysis and Hazard ratio.
The various areas that Anthony G Marson examines in his Carbamazepine study include Standard treatment, Confidence interval, Genotype, Levetiracetam and Phenytoin.
His most cited work include:
- De novo mutations in epileptic encephalopathies (1040 citations)
- Analysis of shared heritability in common disorders of the brain (726 citations)
- Analysis of shared heritability in common disorders of the brain (726 citations)
What are the main themes of his work throughout his whole career to date?
Anthony G Marson mainly investigates Epilepsy, Pediatrics, Randomized controlled trial, Internal medicine and Psychiatry.
Anthony G Marson works on Epilepsy which deals in particular with Lamotrigine.
His studies in Lamotrigine integrate themes in fields like Gabapentin, Valproic Acid, Carbamazepine and Topiramate.
In his research, Phenytoin is intimately related to Hazard ratio, which falls under the overarching field of Pediatrics.
His Randomized controlled trial research incorporates elements of Drug Resistant Epilepsy, Physical therapy and Psychological intervention.
His study in the fields of Cohort under the domain of Internal medicine overlaps with other disciplines such as Adjuvant therapy.
He most often published in these fields:
- Epilepsy (89.21%)
- Pediatrics (41.05%)
- Randomized controlled trial (24.21%)
What were the highlights of his more recent work (between 2019-2021)?
- Epilepsy (89.21%)
- Pediatrics (41.05%)
- Clinical trial (28.16%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Epilepsy, Pediatrics, Clinical trial, Randomized controlled trial and Relative risk.
His Epilepsy research is multidisciplinary, incorporating elements of Internal medicine, Adverse effect and Drug resistance.
His Pediatrics study incorporates themes from Meta-analysis, Status epilepticus, Seizure recurrence and Etiology.
His study in Clinical trial is interdisciplinary in nature, drawing from both Intervention, Proportional hazards model, Confidence interval and Statistical power.
Anthony G Marson has included themes like Sciatica and Individual participant data in his Randomized controlled trial study.
Anthony G Marson has researched Relative risk in several fields, including Placebo and Tolerability.
Between 2019 and 2021, his most popular works were:
- Ketogenic Diets as an Adjuvant Therapy for Glioblastoma (KEATING): A Randomized, Mixed Methods, Feasibility Study (9 citations)
- Ketogenic Diets as an Adjuvant Therapy for Glioblastoma (KEATING): A Randomized, Mixed Methods, Feasibility Study (9 citations)
- A call from the European Academy of Neurology on COVID-19. (6 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Epilepsy
- Gene
Anthony G Marson mostly deals with Epilepsy, Pediatrics, Levetiracetam, Placebo and Relative risk.
The various areas that Anthony G Marson examines in his Pediatrics study include Lamotrigine and Randomized controlled trial.
The concepts of his Lamotrigine study are interwoven with issues in SNP, Genome-wide association study, Crossover study, Bioinformatics and Adverse effect.
Anthony G Marson interconnects Event, Censoring, Physical medicine and rehabilitation and Individual participant data in the investigation of issues within Randomized controlled trial.
His Levetiracetam research includes elements of Quality of life, Hazard ratio, Drug resistance and Intensive care medicine.
His studies in Placebo integrate themes in fields like Meta-analysis, Tolerability, Clinical trial and Vigabatrin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
